Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial

INTRODUCTION: The rapid worldwide spread of COVID-19 has caused a global health crisis. To date, symptomatic supportive care has been the most common treatment. It has been reported that the mechanism of COVID-19 is related to cytokine storms and subsequent immunogenic damage, especially damage to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Zhu, Yuan, Zhang, Jing, Li, Yiming, Peng, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348463/
https://www.ncbi.nlm.nih.gov/pubmed/32641343
http://dx.doi.org/10.1136/bmjopen-2020-039519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348463/
https://www.ncbi.nlm.nih.gov/pubmed/32641343
http://dx.doi.org/10.1136/bmjopen-2020-039519

Ejemplares similares